Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis.

Ke ShiYao LiuXiaojing WangYuxin LiQun ZhangYing HuChongping RanYunyi HuangJie HouXian-Bo Wang

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

FZHY combined with NAs was associated with a significantly lower risk of HCC than NAs alone in patients with HBC, which supports the integration of FZHY with antiviral treatment into clinical practice.

Keyphrases

clinical practice
early stage
risk factors